echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Huadong Pharmaceutical Group 3.1 antifungal drug kapofungin acetate applied for production accepted

    Huadong Pharmaceutical Group 3.1 antifungal drug kapofungin acetate applied for production accepted

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the information on April 3 on the website of the State Food and Drug Administration (CFDA), the application for the production of 3.1 antifungal drug kapofen acetate was accepted

    According to the public information, kapofungin acetate is suitable for the treatment of invasive aspergillosis that is ineffective or intolerable to other treatments, as well as for the suspected fungal infection of people with neutropenia and fever

    The original research drug is "Kosis" developed by MSD, which entered the Chinese market in 2009

    CFDA shows that at present, only the original research drug is on sale in China, and there is no domestic enterprise producing kapofungin acetate API and related preparations

    In addition to Huadong pharmaceutical, Hengrui Pharmaceutical (600276

    SH) has applied for the production approval documents of carbaryl acetate API and injection, and aosaikang has applied for the production approval documents of API

    East China medicine is the leading double ingredient in the field of immunity and hypoglycemic drugs in China

    The field of anti severe infection, anti-tumor and cardiovascular is the new field that the company will focus on in the next three years.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.